if you're glad that I'm positive on PTX-100, now listen to this: statistically, PTX-100 has a chance of 15% to succeed from here.
yes I'm still positive, not because I'm convicted that it will eventually gain FDA approval, and even after that, commercialisation success, after all it's just a 15% chance, but that things have been good, foundation's solid, the path moving forward is clear, none of which will guarantee a success, but it's as good as you can get.
as to omnicar and cellpryme, I was referring to my assessment in late January and reasons given then, hence said "further confirmed" also for the same reasons, by saying the targeted potential partners were "being polite" and "hard truth", I was implying something much worse than what you put as "tightening of money".
things progress, we assess, we make decisions, we share ideas and lookouts. if I was wrong, in this omnicar and cellpryme case, I'll be happier than I was right, cause it will be a pleasant surprise and I gain additional (to what being expected) value in this investment.
E.
PTX Price at posting:
10.5¢ Sentiment: Hold Disclosure: Held
